Orexinergic input to dopaminergic neurons of the human ventral tegmental area

PLoS ONE

Volumn 8, Issue 12, 2013, Pages

  Hrabovszky, Erik ^a   Molnár, Csilla S ^a   Borsay, Beáta Á ^b   Gergely, Péter ^b   Herczeg, László ^b   Liposits, Zsolt ^a,c  

^a INSTITUTE OF EXPERIMENTAL MEDICINE   (Hungary)

^b UNIVERSITY OF DEBRECEN   (Hungary)

^c PÁZMÁNY PÉTER CATHOLIC UNIVERSITY   (Hungary)

Author keywords

[No Author keywords available]

Indexed keywords

OREXIN B; TYROSINE 3 MONOOXYGENASE;

ADULT; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CELL COMPARTMENTALIZATION; CONTROLLED STUDY; DENDRITE; DOPAMINERGIC NERVE CELL; HUMAN; HUMAN CELL; HUMAN TISSUE; INNERVATION; MALE; MIDDLE AGED; NERVE CELL; NERVE FIBER; NERVOUS SYSTEM FUNCTION; NEUROANATOMY; NONHUMAN; OREXINERGIC INNERVATION; OREXINERGIC NEURON; PERIKARYON; RAT; SUBSTANTIA NIGRA; VENTRAL TEGMENTAL AREA NEURON; VENTRAL TEGMENTUM;

ADULT; ANIMALS; AXONS; DOPAMINERGIC NEURONS; GENE EXPRESSION; HUMANS; HYPOTHALAMUS; IMMUNOHISTOCHEMISTRY; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; MALE; MIDDLE AGED; NEUROPEPTIDES; RATS; RATS, WISTAR; REWARD; SUBSTANCE-RELATED DISORDERS; SUBSTANTIA NIGRA; TYROSINE 3-MONOOXYGENASE; VENTRAL TEGMENTAL AREA;

EID: 84893364473     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0083029     Document Type: Article

References (49)

1. Sakurai T, Amemiya A, Ishii M, Matsuzaki I, Chemelli RM, et al. (1998) Orexins and orexin receptors: a family of hypothalamic neuropeptides and G protein-coupled receptors that regulate feeding behavior. Cell 92: 573-585. (Pubitemid 28101119)
2. Chemelli RM, Willie JT, Sinton CM, Elmquist JK, Scammell T, et al. (1999) Narcolepsy in orexin knockout mice: molecular genetics of sleep regulation. Cell 98: 437-451. (Pubitemid 29402482)
3. Harris GC, Wimmer M, Aston-Jones G (2005) A role for lateral hypothalamic orexin neurons in reward seeking. Nature 437: 556-559. (Pubitemid 41613553)
4. Sharf R, Sarhan M, Dileone RJ (2010) Role of orexin/hypocretin in dependence and addiction. Brain research 1314: 130-138.
5. Date Y, Ueta Y, Yamashita H, Yamaguchi H, Matsukura S, et al. (1999) Orexins, orexigenic hypothalamic peptides, interact with autonomic, neuroendocrine and neuroregulatory systems. Proceedings of the National Academy of Sciences of the United States of America 96: 748-753. (Pubitemid 29061280)
6. de Lecea L, Kilduff TS, Peyron C, Gao X, Foye PE, et al. (1998) The hypocretins: hypothalamus-specific peptides with neuroexcitatory activity. Proceedings of the National Academy of Sciences of the United States of America 95: 322-327. (Pubitemid 28103952)
7. Peyron C, Tighe DK, van den Pol AN, de Lecea L, Heller HC, et al. (1998) Neurons containing hypocretin (orexin) project to multiple neuronal systems. The Journal of neuroscience : the official journal of the Society for Neuroscience 18: 9996-10015.
8. Baldo BA, Daniel RA, Berridge CW, Kelley AE (2003) Overlapping distributions of orexin/hypocretin- and dopamine-beta-hydroxylase immunoreactive fibers in rat brain regions mediating arousal, motivation, and stress. The Journal of comparative neurology 464: 220-237. (Pubitemid 36976049)
9. Fadel J, Deutch AY (2002) Anatomical substrates of orexin-dopamine interactions: lateral hypothalamic projections to the ventral tegmental area. Neuroscience 111: 379-387. (Pubitemid 34442621)
10. Nakamura T, Uramura K, Nambu T, Yada T, Goto K, et al. (2000) Orexin-induced hyperlocomotion and stereotypy are mediated by the dopaminergic system. Brain research 873: 181-187. (Pubitemid 30468504)
11. Balcita-Pedicino JJ, Sesack SR (2007) Orexin axons in the rat ventral tegmental area synapse infrequently onto dopamine and gamma-aminobutyric acid neurons. The Journal of comparative neurology 503: 668-684. (Pubitemid 47184584)
12. Narita M, Nagumo Y, Hashimoto S, Khotib J, Miyatake M, et al. (2006) Direct involvement of orexinergic systems in the activation of the mesolimbic dopamine pathway and related behaviors induced by morphine. The Journal of neuroscience : the official journal of the Society for Neuroscience 26: 398-405.
13. Lu XY, Bagnol D, Burke S, Akil H, Watson SJ (2000) Differential distribution and regulation of OX1 and OX2 orexin/hypocretin receptor messenger RNA in the brain upon fasting. Hormones and behavior 37: 335-344. (Pubitemid 30432352)
14. Korotkova TM, Sergeeva OA, Eriksson KS, Haas HL, Brown RE (2003) Excitation of ventral tegmental area dopaminergic and nondopaminergic neurons by orexins/hypocretins. The Journal of neuroscience : the official journal of the Society for Neuroscience 23: 7-11.
15. Vittoz NM, Schmeichel B, Berridge CW (2008) Hypocretin/orexin preferentially activates caudomedial ventral tegmental area dopamine neurons. The European journal of neuroscience 28: 1629-1640.
16. Vittoz NM, Berridge CW (2006) Hypocretin/orexin selectively increases dopamine efflux within the prefrontal cortex: involvement of the ventral tegmental area. Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 31: 384-395.
17. Borgland SL, Taha SA, Sarti F, Fields HL, Bonci A (2006) Orexin A in the VTA is critical for the induction of synaptic plasticity and behavioral sensitization to cocaine. Neuron 49: 589-601. (Pubitemid 43221893)
18. Baimel C, Borgland SL (2012) Hypocretin modulation of drug-induced synaptic plasticity. Progress in brain research 198: 123-131.
19. Korotkova TM, Eriksson KS, Haas HL, Brown RE (2002) Selective excitation of GABAergic neurons in the substantia nigra of the rat by orexin/hypocretin in vitro. Regulatory peptides 104: 83-89. (Pubitemid 34119377)
20. Mai J, Paxinos G, Voss T, editors (2008) Atlas of the human brain. Third edition ed. San Diego: Academic Press.
21. Paxinos G, Watson C (1998) The Rat Brain in Stereotaxic Coordinates. San Diego, CA: Academic Press.
22. Hrabovszky E, Ciofi P, Vida B, Horvath MC, Keller E, et al. (2010) The kisspeptin system of the human hypothalamus: sexual dimorphism and relationship with gonadotropin-releasing hormone and neurokinin B neurons. Eur J Neurosci 31: 1984-1998.
23. Deurveilher S, Lo H, Murphy JA, Burns J, Semba K (2006) Differential c-Fos immunoreactivity in arousal-promoting cell groups following systemic administration of caffeine in rats. The Journal of comparative neurology 498: 667-689. (Pubitemid 44350357)
24. Bullmann T, Hartig W, Holzer M, Arendt T (2010) Expression of the embryonal isoform (0N/3R) of the microtubule-associated protein tau in the adult rat central nervous system. The Journal of comparative neurology 518: 2538-2553.
25. Fronczek R, Lammers GJ, Balesar R, Unmehopa UA, Swaab DF (2005) The number of hypothalamic hypocretin (orexin) neurons is not affected in Prader-Willi syndrome. J Clin Endocrinol Metab 90: 5466-5470. (Pubitemid 41262317)
26. Liposits Z, Setalo G, Flerko B (1984) Application of the silver-gold intensified 3,3′-diaminobenzidine chromogen to the light and electron microscopic detection of the luteinizing hormone-releasing hormone system of the rat brain. Neuroscience 13: 513-525. (Pubitemid 15211954)
27. Hrabovszky E, Molnar CS, Sipos M, Vida B, Ciofi P, et al. (2011) Sexual dimorphism of kisspeptin and neurokinin B immunoreactive neurons in the infundibular nucleus of aged men and women. Frontiers in Endocrinology 2: 80.
28. Molnar CS, Vida B, Sipos MT, Ciofi P, Borsay BA, et al. (2012) Morphological evidence for enhanced kisspeptin and neurokinin B signaling in the infundibular nucleus of the aging man. Endocrinology 153: 5428-5439.
29. Harris GC, Aston-Jones G (2006) Arousal and reward: a dichotomy in orexin function. Trends in neurosciences 29: 571-577. (Pubitemid 44416459)
30. Aston-Jones G, Smith RJ, Moorman DE, Richardson KA (2009) Role of lateral hypothalamic orexin neurons in reward processing and addiction. Neuropharmacology 56 Suppl 1: 112-121.
31. Boutrel B, Steiner N, Halfon O (2013) The hypocretins and the reward function: what have we learned so far? Front Behav Neurosci 7: 59.
32. Georgescu D, Zachariou V, Barrot M, Mieda M, Willie JT, et al. (2003) Involvement of the lateral hypothalamic peptide orexin in morphine dependence and withdrawal. The Journal of neuroscience : the official journal of the Society for Neuroscience 23: 3106-3111.
33. Sharf R, Sarhan M, Dileone RJ (2008) Orexin mediates the expression of precipitated morphine withdrawal and concurrent activation of the nucleus accumbens shell. Biological psychiatry 64: 175-183.
34. Hollander JA, Lu Q, Cameron MD, Kamenecka TM, Kenny PJ (2008) Insular hypocretin transmission regulates nicotine reward. Proceedings of the National Academy of Sciences of the United States of America 105: 19480-19485.
35. Lawrence AJ, Cowen MS, Yang HJ, Chen F, Oldfield B (2006) The orexin system regulates alcohol-seeking in rats. British journal of pharmacology 148: 752-759. (Pubitemid 44079404)
36. Srinivasan S, Simms JA, Nielsen CK, Lieske SP, Bito-Onon JJ, et al. (2012) The dual orexin/hypocretin receptor antagonist, almorexant, in the ventral tegmental area attenuates ethanol self-administration. PloS one 7: e44726.
37. Boutrel B, Kenny PJ, Specio SE, Martin-Fardon R, Markou A, et al. (2005) Role for hypocretin in mediating stress-induced reinstatement of cocaine-seeking behavior. Proceedings of the National Academy of Sciences of the United States of America 102: 19168-19173. (Pubitemid 43049584)
38. Wang B, You ZB, Wise RA (2009) Reinstatement of cocaine seeking by hypocretin (orexin) in the ventral tegmental area: independence from the local corticotropin-releasing factor network. Biological psychiatry 65: 857-862.
39. Dayas CV, McGranahan TM, Martin-Fardon R, Weiss F (2008) Stimuli linked to ethanol availability activate hypothalamic CART and orexin neurons in a reinstatement model of relapse. Biological psychiatry 63: 152-157. (Pubitemid 350299313)
40. Mahler SV, Smith RJ, Moorman DE, Sartor GC, Aston-Jones G (2012) Multiple roles for orexin/hypocretin in addiction. Progress in brain research 198: 79-121.
41. Di Sebastiano AR, Coolen LM (2012) Orexin and natural reward: feeding, maternal, and male sexual behavior. Progress in brain research 198: 65-77.
42. Bisetti A, Cvetkovic V, Serafin M, Bayer L, Machard D, et al. (2006) Excitatory action of hypocretin/orexin on neurons of the central medial amygdala. Neuroscience 142: 999-1004. (Pubitemid 44636051)
43. Xia J, Chen X, Song C, Ye J, Yu Z, et al. (2005) Postsynaptic excitation of prefrontal cortical pyramidal neurons by hypocretin-1/orexin A through the inhibition of potassium currents. Journal of neuroscience research 82: 729-736. (Pubitemid 41740472)
44. Martin G, Fabre V, Siggins GR, de Lecea L (2002) Interaction of the hypocretins with neurotransmitters in the nucleus accumbens. Regulatory peptides 104: 111-117. (Pubitemid 34119381)
45. Mukai K, Kim J, Nakajima K, Oomura Y, Wayner MJ, et al. (2009) Electrophysiological effects of orexin/hypocretin on nucleus accumbens shell neurons in rats: an in vitro study. Peptides 30: 1487-1496.
46. Barrot M, Sesack SR, Georges F, Pistis M, Hong S, et al. (2012) Braking dopamine systems: a new GABA master structure for mesolimbic and nigrostriatal functions. J Neurosci 32: 14094-14101.
47. Hirsch E, Graybiel AM, Agid YA (1988) Melanized dopaminergic neurons are differentially susceptible to degeneration in Parkinson's disease. Nature 334: 345-348.
48. Sulzer D, Bogulavsky J, Larsen KE, Behr G, Karatekin E, et al. (2000) Neuromelanin biosynthesis is driven by excess cytosolic catecholamines not accumulated by synaptic vesicles. Proceedings of the National Academy of Sciences of the United States of America 97: 11869-11874.
49. Kotz CM, Wang C, Teske JA, Thorpe AJ, Novak CM, et al. (2006) Orexin A mediation of time spent moving in rats: neural mechanisms. Neuroscience 142: 29-36. (Pubitemid 44354985)